SYNTERA BIORISK
SpeciesCattle & deerReleaseGermany · 2026-09-07
  1. Global Overview
  2. Europe
  3. Germany
  4. Epizootic haemorrhagic disease
Country–disease dossierGermany · Epizootic haemorrhagic disease
View economic evidence Run scenarioCompare interventionsInspect BCR assumptions Vaccine & intervention marketTrade analysis
Germany cross-disease portfolio GERMANY DISEASE PROFILE · LINKED WORKSPACE

Epizootic haemorrhagic disease

Official evidence, 16-state exposure and transparent national planning economics.

Profile readyEvidence + editable CBA
African swine feverongoing wild boar circulation regionalised controlsHighly pathogenic avian influenzacurrent 2026 poultry and wild bird activityBluetongueactive btv3 and btv8 circulationBovine tuberculosiseu disease free whole territoryFoot-and-mouth diseaseofficially free without vaccination after 2025 eventPeste des petits ruminantsofficially free external european incursion riskNewcastle diseasecurrent 2026 commercial poultry outbreaksClassical swine feverofficially freeSheep pox and goat poxfree since 1920 external incursion preparednessLumpy skin diseaseno current domestic event heightened external riskBovine viral diarrhoeanear national freedom with three residual zonesJohne’s diseasereportable endemic hygiene controlEpizootic haemorrhagic diseasenotifiable external vector incursion risk
Official disease status · 2025-05-15

Epizootic haemorrhagic disease

EHD is notifiable in Germany. The latest registered FLI assessment rated EHDV-8 introduction risk as high from May to October through windborne midges combined with legal trade; no current domestic series is registered here.

Selected geography
Germany
Susceptible livestock
12.84m
Evidence nature
Observed / official
Exposure layer

Germany · susceptible livestock

BKG VG250 2026
Exposure is livestock inventory—not inferred prevalence. Regional selection updates supported evidence; the CBA remains explicitly national because regional cost evidence is unavailable.
Validated exposure

Germany

cattle10.85m
sheep1.82m
goats162.6k

Destatis 41141-0104 · 1 Mar 2023 observations; source grain retained.

Official signal at selected grain

No numeric national event series is published in the registered official source. The status narrative remains available.

Observed economics · national/source scope
Observed direct loss · national
N/A
Published programme cost · source scope
N/A
Monetised trade effect
N/A

No compatible current Germany-specific direct-loss estimate is registered; no value is inferred.

Relevant wildlife & interface

Wildlife evidence

No compatible current national wildlife-population layer is registered.

Population denominators remain unavailable unless explicitly registered; qualitative host evidence is not converted into a count.
ILLUSTRATIVE

Illustrative scenario—country-specific intervention evidence unavailable.

The planning parameters are retained, but the BCR is not estimated in this public profile.

Open Impact CalculatorWhy these assumptions?
Control choices

Default option scenarios

  1. 01Vector surveillancePlanning option retained for explicit activation in Scenario Lab
  2. 02Rapid notificationPlanning option retained for explicit activation in Scenario Lab
  3. 03EU movement certificationPlanning option retained for explicit activation in Scenario Lab
Trade & movement

Documented consequence

Notification, vector surveillance, testing and movement certification are the registered preparedness levers; no licensed EHD vaccine is assumed.

Registered sources document controls but not a compatible Germany-wide monetised trade consequence.
Evidence register

4 sources used in this view

Release principle: every Germany disease has a complete decision workspace. Missing observed economics stay visible as N/A; modelled planning values are separately labelled, editable and never presented as evidence.
Sustainability & One HealthCountry-specific GHG, AMU/AMR and biodiversity results remain withheld until compatible evidence is registered; none is inferred from the disease profile.
Request complete Decision Brief